Collegium Pharmaceutical, Inc. (COLL)

Collegium Pharmaceutical Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	1,059	1,004	779	646	693	690
Market Cap Growth	51.81%	28.87%	20.62%	-6.78%	0.39%	20.87%
Enterprise Value	1,370	1,366	1,312	716	783	542
PE Ratio	13.43	20.84	-31.15	9.03	25.89	-30.37
PS Ratio	1.87	1.77	1.68	2.33	2.23	2.33
PB Ratio	4.77	5.14	4.00	3.18	3.72	7.89
P/FCF Ratio	3.44	3.66	6.35	6.35	-2.48	32.33
P/OCF Ratio	3.43	3.65	6.27	6.24	7.37	24.83
EV/Sales Ratio	2.42	2.41	2.83	2.58	2.52	1.83
EV/EBITDA Ratio	3.82	4.43	7.57	8.27	6.63	-26.08
EV/EBIT Ratio	6.55	8.59	38.17	40.56	13.86	-24.83
EV/FCF Ratio	4.44	4.98	10.70	7.04	-2.80	25.37
Debt / Equity Ratio	2.84	3.45	3.64	1.28	1.43	0.25
Debt / EBITDA Ratio	1.76	2.19	4.09	2.99	2.26	-1.04
Debt / FCF Ratio	2.04	2.46	5.78	2.55	-0.95	1.01
Quick Ratio	1.11	1.07	0.83	1.05	1.09	1.20
Current Ratio	1.21	1.17	0.97	1.13	1.16	1.27
Asset Turnover	0.49	0.48	0.38	0.40	0.48	0.98
Interest Coverage	2.64	1.91	0.54	0.84	1.95	-24.00
Return on Equity (ROE)	46.80%	25.50%	-12.70%	32.60%	16.30%	-26.40%
Return on Assets (ROA)	8.00%	4.10%	-2.10%	10.20%	4.20%	-7.50%
Return on Capital (ROIC)	16.16%	12.21%	3.69%	3.82%	12.05%	-21.78%
Earnings Yield	8.81%	4.80%	-3.21%	11.08%	3.86%	-3.29%
FCF Yield	29.11%	27.33%	15.74%	15.74%	-40.40%	3.09%
Buyback Yield / Dilution	-20.74%	-23.53%	17.58%	-16.77%	-5.07%	-1.52%
Total Shareholder Return	-20.74%	-23.53%	17.58%	-16.77%	-5.07%	-1.52%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).